Law360, New York (May 21, 2012, 3:45 PM ET) -- The U.S. Supreme Court refused Monday to hear a case regarding evidence limits in patent infringement disputes, a month after deciding that patent applicants should not be restricted from presenting new evidence to federal courts when challenging a patent office rejection.
The high court denied blood test technology company Research & Diagnostics Systems Inc.'s petition for writ of certiorari. R&D had asked the Supreme Court to review the level of deference given to U.S. Patent and Trademark Office administrative decisions after they are appealed to federal...